4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide

C15H17N5O3 — CID 110396026

IUPAC4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide
SMILESCc1nnc(C(=O)N2CCN(C(=O)Nc3ccccc3)CC2)o1
InChIInChI=1S/C15H17N5O3/c1-11-17-18-13(23-11)14(21)19-7-9-20(10-8-19)15(22)16-12-5-3-2-4-6-12/h2-6H,7-10H2,1H3,(H,16,22)
InChIKeyNOXZMXUIRSBZMI-UHFFFAOYSA-N
MW315.33 g/mol
LogP1.37
Rot. Bonds2

About 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide

4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide (PubChem CID 110396026) has the molecular formula C15H17N5O3 and a molecular weight of 315.33 g/mol. Its IUPAC name is 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide.

Molecular Properties

Compound Name4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide
PubChem CID110396026
Molecular FormulaC15H17N5O3
Molecular Weight315.33 g/mol
Exact Mass315.13
IUPAC Name4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide
SMILESCc1nnc(C(=O)N2CCN(C(=O)Nc3ccccc3)CC2)o1
InChIInChI=1S/C15H17N5O3/c1-11-17-18-13(23-11)14(21)19-7-9-20(10-8-19)15(22)16-12-5-3-2-4-6-12/h2-6H,7-10H2,1H3,(H,16,22)
InChIKeyNOXZMXUIRSBZMI-UHFFFAOYSA-N
XLogP1.37
TPSA91.57 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500315.33
LogP ≤ 51.37
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-phenyl-4-(5-propan-2-yl-1,3,4-oxadiazole-2-carbonyl)piperazine-1-carboxamide
CID 110396572
4-(2,5-dimethylfuran-3-carbonyl)-N-phenylpiperazine-1-carboxamide
CID 51276164
2,2-dimethyl-1-[4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)piperazin-1-yl]propan-1-one
CID 110395984
N-(4-chlorophenyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperazine-1-carboxamide
CID 110419056
4-benzoyl-N-(3-methylphenyl)piperazine-1-carboxamide
CID 18101727
2-[4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)piperazin-1-yl]sulfonylbenzonitrile
CID 110396125
N-phenyl-4-(thiophene-2-carbonyl)piperazine-1-carboxamide
CID 51186037
4-(2-methoxy-5-methylbenzoyl)-N-phenyl-1,4-diazepane-1-carboxamide
CID 110813373
1-N,4-N-bis(4-methylphenyl)piperazine-1,4-dicarboxamide
CID 4055899
4,4-dimethyl-N-phenylpiperidine-1-carboxamide
CID 110749467
N-phenyl-4-propylpiperazine-1-carboxamide
CID 17383007
4-(2-chlorobenzoyl)-N-phenyl-1,4-diazepane-1-carboxamide
CID 110811610

Frequently Asked Questions

What is the IUPAC name of 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide?
The IUPAC name of 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide (CID 110396026) is 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide.
What is the SMILES notation for 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide?
The canonical SMILES for 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide is Cc1nnc(C(=O)N2CCN(C(=O)Nc3ccccc3)CC2)o1.
What is the InChIKey of 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide?
The InChIKey is NOXZMXUIRSBZMI-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17N5O3/c1-11-17-18-13(23-11)14(21)19-7-9-20(10-8-19)15(22)16-12-5-3-2-4-6-12/h2-6H,7-10H2,1H3,(H,16,22).
What are the key properties of 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide?
4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide has a molecular weight of 315.33 g/mol, XLogP of 1.37, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(5-methyl-1,3,4-oxadiazole-2-carbonyl)-N-phenylpiperazine-1-carboxamide is sourced from PubChem (CID 110396026), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).